• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
URB597

URB597

Product ID U682040
Cas No. 546141-08-6
Purity ≥98%
Product Unit SizeCostQuantityStock
5 mg $57.20 In stock
25 mg $193.30 In stock
100 mg $565.10 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

URB597 is an inhibitor of fatty acid amide hydrolase (FAAH). FAAH inhibition leads to an increase of anandamide, a naturally occurring substrate for the cannabinoid receptors. Increase in anandamide and activation of the CB receptors decreases sensitivity to pain in rat models. Additionally, URB597 also decreases the amount of tyrosine hydrolase in neurons in a CB receptor/FAAH independent manner. URB597 also demonstrates an anti-neuroinflammatory effect in Sprague-Dawley rat models. URB597 shows analgesic effects in numerous pain models

Product Info

Cas No.

546141-08-6

Purity

≥98%

Formula

C20H22N2O3

Formula Wt.

338.41

Chemical Name

Cyclohexylcarbamic acid 3´-carbamoyl-biphenyl-3-yl ester

IUPAC Name

[3-(3-carbamoylphenyl)phenyl] N-cyclohexylcarbamate

Solubility

50mM in DMSO

Appearance

White powder

Shipping and Storage

Store Temp

-20°C

Ship Temp

Ambient

Downloads

MSDS

U682040 MSDS PDF

Info Sheet

U682040 Info Sheet PDF

References

Murphy N, Cowley TR, Blau CW et al. The fatty acid amide hydrolase inhibitor URB597 exerts anti-inflammatory effects in hippocampus of aged rats and restores an age-related deficit in long-term potentiation. J Neuroinflammation. 2012 Apr 26;9:79. PMID: 22537429.

Bosier B, Muccioli GG, and Lamber DM. The FAAH inhibitor URB597 efficiently reduces tyrosine hydroxylase expression through CB1 and FAAH-independent mechanisms. Br J Pharmacol. 2013 Jun;169(4):794-807. PMID: 22970888

Kwilasz AJ, Abdullah RA, Poklis JL et al. Effects of the fatty acid amide hydrolase inhibitor URB597 on pain-stimulated and pain-depressed behavior in rats. Behav Pharmacol. 2014 Apr;25(2):119-29. PMID: 24583930

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • B6957

    Bromhexine Hydrochloride

    Synthetic derivative of vasicine, mucolytic.

    ≥98%
  • T1855

    Tentoxin

    Cyclic peptide mycotoxin produced by Alternaria...

    ≥98%, HPLC
  • D022705

    Darunavir

    HIV and AIDS

    ≥99%
  • D183734

    7-O-Desmethyl Rapamycin

    Rapamycin impurity

    ≥85%
  • C7098

    Crystalline peptide

    Dipeptide.

    ≥95%
  • B4514

    Bleomycin A5 Hydrochloride Cu

    Induces apoptosis, DNA cleavage and strand brea...

    ≥85%
  • C5773

    Cortistatin-14

    Endogenous neuropeptide, somatostatin analog; s...

    ≥95%
  • A0534

    Abiraterone

    Progesterone derivative; Cyp17A1 inhibitor.

    ≥99%
  • N1984

    Neuropeptide FF

    Endogenous RF-amide peptide, involved in nocice...

    ≥95%
  • T3324

    Tigecycline

    Glycylcycline; protein synthesis inhibitor.

    ≥98%
  • K0144

    Kallikrein Inhibitor

    Peptide; serine protease inhibitor.

    ≥95%
  • R0020

    RAF265

    B-Raf, VEGFR2, c-Raf, PDGFR, CSF-1R, RET, c-Kit...

    ≥98%
  • E6814

    Erdosteine

    Thiol derivative, antioxidant.

    ≥98%
  • K5606

    Kobe 2602

    Ras inhibitor.

    ≥98%
  • L1881

    Leuprolide Acetate

    GnRH analog; GnRH1 agonist.

    ≥95%
  • A4002

    AK-7

    SIRT2 inhibitor.

    ≥98%
  • S800000

    SU-9516

    CDK2 inhibitor.

    ≥98%
  • C8500

    CV-65

    1,8-Diaza-anthracene-tetrone; JNK and ERK5 inhi...

    ≥70%
  • C1624

    Cefuroxime Sodium

    β-lactam; penicillin binding protein inhibitor...

    ≥98%
  • N7604

    Naltriben

    δ2OR antagonist.

    ≥95%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2025 LKT Laboratories, All Rights Reserved - Products for research use only